{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:24:31Z","timestamp":1791854671228,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.drugalcdep.2015.12.035","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T12:34:21Z","timestamp":1452688461000},"page":"82-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-1490","authenticated-orcid":false,"given":"Ajay","family":"Manhapra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantie","family":"Quinones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rosenheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0005","series-title":"The New Jim Crow: Mass Incarceration in the Age of Colorblindness","author":"Alexander","year":"2012"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archinte.167.2.166","article-title":"Injection drug users in the United States: 1979\u20132002: an aging population","volume":"167","author":"Armstrong","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1360-0443.2009.02539.x","article-title":"Comparison of costs and utilization among buprenorphine and methadone patients","volume":"104","author":"Barnett","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsat.2011.02.002","article-title":"Factors associated with medicaid patients\u2019 access to buprenorphine treatment","volume":"41","author":"Baxter","year":"2011","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1370\/afm.1242","article-title":"Racial differences in primary care opioid risk reduction strategies","volume":"9","author":"Becker","year":"2011","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse dependence, and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.drugalcdep.2007.11.020","article-title":"Racial and ethnic changes in heroin injection in the United States: implications for the HIV\/AIDS epidemic","volume":"94","author":"Broz","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/pds.1452","article-title":"Relationship between therapeutic use and abuse of opioid analgesics in rural suburban, and urban locations in the United States","volume":"16","author":"Cicero","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0055","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s11524-008-9304-9","article-title":"Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992\u20132002): estimation methods and prevalence trends","volume":"85","author":"Cooper","year":"2008","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0060","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jama.288.7.850","article-title":"Changes in methadone treatment practices: results from a national panel study, 1988\u20132000","volume":"288","author":"D\u2019Aunno","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jama.1992.03480020063032","article-title":"Variations in methadone treatment practices results from a national study","volume":"267","author":"D\u2019Aunno","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0070","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1360-0443.2006.01495.x","article-title":"Systemic disease among cases of fatal opioid toxicity","volume":"101","author":"Darke","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.07.014","article-title":"The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases","volume":"106","author":"Darke","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0080","first-page":"3","article-title":"The effectiveness of coerced treatment for drug-abusing offenders","volume":"62","author":"Farabee","year":"1998","journal-title":"Fed. Probat."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0085","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1037\/a0015808","article-title":"An effect size primer: a guide for clinicians and researchers","volume":"40","author":"Ferguson","year":"2009","journal-title":"Prof. Psychol. Res. Pract."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0090","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMcp013579","article-title":"Clinical practice: office-based treatment of opioid-dependent patients","volume":"347","author":"Fiellin","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/08897077.2013.819828","article-title":"A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment","volume":"35","author":"Fingerhood","year":"2014","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0100","article-title":"U.S. Department of Veterans Affairs Veterans Justice Outreach Program: connecting justice-involved veterans with mental health and substance use disorder treatment","author":"Finlay","year":"2014","journal-title":"Crim. Justice Policy Rev. Epub."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1360-0443.2003.00673.x","article-title":"Heroin diffusion in the mid-Hudson region of New York State","volume":"99","author":"Furst","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1176\/appi.ps.51.8.1024","article-title":"Factors predicting choice of provider among homeless veterans with mental illness","volume":"51","author":"Gamache","year":"2000","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/oxfordjournals.aje.a112012","article-title":"An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction","volume":"100","author":"Gearing","year":"1974","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0130","first-page":"48","article-title":"Models for implementing buprenorphine treatment in the VHA","volume":"26","author":"Gordon","year":"2009","journal-title":"Fed. Pract."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/a0022776","article-title":"Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration","volume":"25","author":"Gordon","year":"2011","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1026096123010","article-title":"Change in mental health service delivery among blacks, whites, and hispanics in the Department of Veterans Affairs","volume":"31","author":"Greenberg","year":"2003","journal-title":"Adm. Policy Ment. Health"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0150","first-page":"e1","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","author":"Jones","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0155","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users\u2014United States, 2002\u20132013","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","article-title":"Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients","volume":"33","author":"Maremmani","year":"2007","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1744-859X-10-17","article-title":"Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?","volume":"10","author":"Maremmani","year":"2011","journal-title":"Ann. Gen. Psychiatr."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"Every \u2018never\u2019 i ever said came true: transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0175","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2015.03.020","article-title":"Racial\/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users","volume":"151","author":"Martins","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00952990.2012.741167","article-title":"Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand?","volume":"39","author":"Oliva","year":"2013","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/ADM.0b013e318287cfc9","article-title":"Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry","volume":"7","author":"Peles","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0195","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1037\/a0037550","article-title":"A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite study","volume":"22","author":"Proctor","year":"2014","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0200","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.addbeh.2014.01.016","article-title":"Impact of research network participation on the adoption of buprenorphine for substance abuse treatment","volume":"39","author":"Rieckmann","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0205","unstructured":"SAMHSA, 2007. The DASIS Report: Heroin\u2014Changes In How It Is Used: 1995\u20132005. Department Of Health And Human Services, Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0210","unstructured":"SAMHSA, 2011. Treatment Episode Data Set (TEDS) 1999\u20132009. National Admissions to Substance Abuse Treatment Services; DASIS Series: S-56HHS Publication No. (SMA) 11-4646. Department Of Health And Human Services, Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0215","unstructured":"SAMHSA, 2013. Substance Abuse and Mental Health Services Administration 2011 Opioid Treatment Program (OTP) Survey: Data on Substance Abuse Treatment Facilities with OTPs. Center for Behavioral Health Statistics and Quality. Substance Abuse and Mental Health Services Administration, Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.drugalcdep.2012.06.020","article-title":"Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine\/naloxone treatment","volume":"127","author":"Savant","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02791072.1994.10472440","article-title":"Injection drug users in the midwest: an epidemiologic comparison of drug use patterns in four Ohio cities","volume":"26","author":"Siegal","year":"1994","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0230","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ypmed.2006.10.003","article-title":"Years of potential life lost among heroin addicts 33 years after treatment","volume":"44","author":"Smyth","year":"2007","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0235","unstructured":"Stanton, A., 2006. The SAMHSA Evaluation of the Impact of the DATA Waiver Program. Summary Report. WESTAT, Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0240","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine on treatment of opioid dependence in a medicaid population: recent service utilization trends in the use of buprenorphine and methadone","volume":"123","author":"Stein","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2004.12.008","article-title":"The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?","volume":"79","author":"Sullivan","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0250","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-assisted treatment with buprenorphine: assessing the evidence","volume":"65","author":"Thomas","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0255","doi-asserted-by":"crossref","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cct.2010.01.003","article-title":"A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology","volume":"31","author":"Weiss","year":"2010","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2015.12.035_bib0265","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1360-0443.2011.03635.x","article-title":"Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis","volume":"107","author":"Young","year":"2012","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T02:29:13Z","timestamp":1537064953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871616000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":53,"alternative-id":["S0376871616000065"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.035","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}